Researchers looked at how the vaccine affected patients' corneas - the clear front part of the eye that allows light to come ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.

But if there are just as many headaches for Horus Heresy fans once more, then one of Games Workshop’s most beloved book series is going to end in an era of ruin of a different sort.

While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears ...

A dividend yield that surpasses 7.5% from a pharmaceutical sector giant like Pfizer Inc. (NYSE: PFE) certainly catches the eye of income-seeking investors. Such a substantial return often signals ...

Pfizer has bagged ex-China rights, establishing itself as a challenger to BioNTech, Merck and Summit in a scorching-hot area of immuno-oncology.

The release of COVID-19 vaccine results days after the 2020 election may have not been a "coincidence" -- and could have been part of an effort by senior Pfizer executives to "deliberately slow ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until after the 2020 election ...